Delivery Order SPE2DB22D1017-SPE2DB25FYPVL
Award Date 9/3/25
Potential Completion Date 9/4/25
Potential Value $4.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,239.90 delivery order to AmerisourceBergen Drug Corp for 30 units of Mesalamine 1,000 mg suppositories under a firm fixed-price contract. The delivery order, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a competitively awarded, non-set-aside procurement executed through the company's existing contract vehicle with DLA. The pharmaceutical product will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Mesalamine 1,000 mg suppositories (30-count units) with a ceiling value of $6,756.20. This is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and was awarded on a competitive basis without any set-aside designation. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Mesalamine 1,000 mg suppositories in a quantity of 30 units, with a ceiling value of $1,768.57. This firm fixed-price delivery order, which is due for completion by August 8, 2025, represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,721.71 to AmerisourceBergen Drug Corp for Mesalamine 1,000 mg suppositories (30-count) on September 9, 2025, with an ultimate completion date of September 10, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and specifies performance at the vendor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX)...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,133.89, is for the delivery of Mesalamine 1,000 mg suppositories. It is a Firm Fixed Price Delivery Order contract with a completion date of March 19, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract...
- The Defense Logistics Agency Troop Support Medical awarded a $77,040 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,000 units of 1,000 mg mesalamine suppositories to be delivered to its Conshohocken, Pennsylvania facility by July 21, 2023. Amerisourcebergen will fulfill the contract as the prime contractor. The award was made using the Medical Prime Vendor Next Generation indefinite-delivery/indefinite-quantity contract vehicle. No subcontractors or set-aside...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $521 to Amerisourcebergen Drug Corporation for the supply of 1,000 30-count bottles of 1,000 mg mesalamine suppositories. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by September 22, 2023 in support of the Defense Logistics Agency's medical supply procurement programs. No subcontractors or set aside designations were...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $14,506.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mesalamine 1.2GM (120 count) with an ultimate completion date of October 15, 2025. The award, issued on September 17, 2025, was competitively awarded with no set-aside designation. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order valued at $9,627.61 to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Mesalamine 800 mg delayed-release tablets in a quantity of 180 units. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award based on open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Mesalamine ER 0.375 gram capsules (120-count). This is a firm fixed price delivery order with a ceiling value of $7,754.63 and an ultimate completion date of September 9, 2025. The award represents a non-competitive procurement and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued...